Central inhibitors of acetylcholinesterase such asdonepezil were shown to reduce the apnea and hypopnea index (AHI) in patients withAD and OSA.48 However, there isinsufficient evidence to indicate the use of this medication for the treatment ofOSA in these patients.49 This evidence concerns the gene ACHE and obstructive sleep apnea syndrome.